Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain [version 2; peer review: 2 approved]

Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain [version 2; peer review: 2 approved]

Background: Although intermittent androgen deprivation therapy was introduced many years ago to improve patients’ quality of life with the same carcinologic efficiency as continuous hormonal therapy, recent data suggest that intermittency could be underutilised. This study aims to estimate the preva...

Full description

Bibliographic Details
Main Authors: Iratxe Urreta, Jose Ignacio Pijoan, José Antonio Cordero, Ariadna Auladell-Rispau, Ignasi Gich, Javier Zamora, Luis Carlos Saiz, Xavier Bonfill-Cosp
Format: Article
Language:English
Published: F1000 Research Ltd 2022-04-01
Series:F1000Research
Subjects:
intermittent androgen deprivation therapy (IAD)
LHRH analogues
prostate cancer
appropriateness
eng
Online Access:https://f1000research.com/articles/10-1069/v2

Similar Items

Similar Items